Detalhe da pesquisa
1.
An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.
Nat Immunol;
23(1): 50-61, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34853448
2.
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
Nat Immunol;
21(11): 1336-1345, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32887977
3.
Increased co-expression of 4-1BB with PD-1 on CD8+ tumor-infiltrating lymphocytes is associated with improved prognosis and immunotherapy response in cervical cancer.
Front Oncol;
14: 1381381, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38756662
4.
Increased co-expression of TIM-3 with TIGIT or 2B4 on CD8+ T cells is associated with poor prognosis in locally advanced nasopharyngeal carcinoma.
Biomol Biomed;
23(4): 584-595, 2023 Jul 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36913701
5.
SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8+ T cell responses.
Heliyon;
9(10): e20076, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37842619
6.
PD-1 Expression Status on CD8+ Tumour Infiltrating Lymphocytes Associates With Survival in Cervical Cancer.
Front Oncol;
11: 678758, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34150643
7.
Association between circulating CD39+CD8+ T cells pre-chemoradiotherapy and prognosis in patients with nasopharyngeal carcinoma.
Chin Med J (Engl);
134(17): 2066-2072, 2021 Aug 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34435978
8.
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells.
iScience;
24(11): 103353, 2021 Nov 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34729465
9.
Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.
bioRxiv;
2020 Jun 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32577665
10.
Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination.
Front Immunol;
6: 287, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26082783